10 Multiplex genotyping of matched EBUS TBNA and cfDNA samples in advanced NSCLC patients (English)
- New search for: Lyons, J.
- New search for: O'Brien, C.
- New search for: Krussel, S.
- New search for: Finn, S.P.
- New search for: Cuffe, S.
- New search for: O'Connell, F.
- New search for: Gately, K.
- New search for: Lyons, J.
- New search for: O'Brien, C.
- New search for: Krussel, S.
- New search for: Finn, S.P.
- New search for: Cuffe, S.
- New search for: O'Connell, F.
- New search for: Gately, K.
In:
Lung cancer
;
91
;
S4
;
2016
-
ISSN:
- Article (Journal) / Print
-
Title:10 Multiplex genotyping of matched EBUS TBNA and cfDNA samples in advanced NSCLC patients
-
Contributors:Lyons, J. ( author ) / O'Brien, C. ( author ) / Krussel, S. ( author ) / Finn, S.P. ( author ) / Cuffe, S. ( author ) / O'Connell, F. ( author ) / Gately, K. ( author )
-
Published in:Lung cancer ; 91 ; S4
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2016-01-01
-
Size:S4
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.99424
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.99424 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 91
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apartDebieuvre, Didier / Oster, Jean-Philippe / Riou, Robert / Berruchon, Jacques / Levy, Antoine / Mathieu, Jean-Pierre / Dumont, Patrick / Leroy-Terquem, Etienne / Tizon-Couetil, Véronique / Martin, Francis et al. | 2016
- 7
-
Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutationsSaruwatari, Koichi / Ikemura, Shinnosuke / Sekihara, Keigo / Kuwata, Takeshi / Fujii, Satoshi / Umemura, Shigeki / Kirita, Keisuke / Matsumoto, Shingo / Yoh, Kiyotaka / Niho, Seiji et al. | 2016
- 15
-
Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancerKim, Gwangil / An, Hee-Jung / Lee, Mi-Jung / Song, Ji-Ye / Jeong, Ju-Yeon / Lee, Ji-Hyun / Jeong, Hye-Cheol et al. | 2016
- 23
-
Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutationsTissot, Claire / Couraud, Sébastien / Tanguy, Ronan / Bringuier, Pierre-Paul / Girard, Nicolas / Souquet, Pierre-Jean et al. | 2016
- 29
-
CT screening for lung cancer: Is the evidence strong enough?Field, J.K. / Devaraj, A. / Duffy, S.W. / Baldwin, D.R. et al. | 2016
- 36
-
Heterogeneity in resistance mechanisms causes shorter duration of epidermal growth factor receptor kinase inhibitor treatment in lung cancerSuda, Kenichi / Murakami, Isao / Sakai, Kazuko / Tomizawa, Kenji / Mizuuchi, Hiroshi / Sato, Katsuaki / Nishio, Kazuto / Mitsudomi, Tetsuya et al. | 2016
- 41
-
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)Rieber, Juliane / Deeg, Alexander / Ullrich, Elena / Foerster, Robert / Bischof, Marc / Warth, Arne / Schnabel, Philipp A. / Muley, Thomas / Kappes, Jutta / Heussel, Claus Peter et al. | 2016
- 48
-
How should pulmonary nodules be optimally investigated and managed?Callister, Matthew E.J. / Baldwin, David R. et al. | 2016
- 56
-
Prognostic significance of hypoxic PET using 18F-FAZA and 62Cu-ATSM in non-small-cell lung cancerKinoshita, Tomonari / Fujii, Hirofumi / Hayashi, Yuichiro / Kamiyama, Ikuo / Ohtsuka, Takashi / Asamura, Hisao et al. | 2016
- 67
-
ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?Vergne, Florence / Quéré, Gilles / Andrieu-Key, Sophie / Descourt, Renaud / Quintin-Roué, Isabelle / Talagas, Matthieu / De Braekeleer, Marc / Marcorelles, Pascale / Uguen, Arnaud et al. | 2016
- 70
-
ALK F1174V mutation confers sensitivity while ALK I1171 mutation confers resistance to alectinib. The importance of serial biopsy post progressionOu, Sai-Hong / Milliken, Jeffrey C. / Azada, Michele C. / Miller, Vincent A. / Ali, Siraj M. / Klempner, Samuel J. et al. | 2016
- 73
-
Rapid clearance of circulating tumor DNA during treatment with AZD9291 of a lung cancer patient presenting the resistance EGFR T790M mutationVallée, Audrey / Audigier-Valette, Clarisse / Herbreteau, Guillaume / Merrien, Julien / Tessonnier, Laurent / Théoleyre, Sandrine / Denis, Marc G. et al. | 2016
- 75
-
Outcomes of octogenarian (≥80 yo) patients with advanced non-small cell lung cancer (NSCLC): A single institution experience at the Christie HospitalHowell, M. / Chiramel, J. / Flaum, N. / Lewis, A. / Summers, Y. / Taylor, P.D. / Chittalia, A. / Sheikh, H. / Blackhall, F. / Califano, R. et al. | 2016
- 77
-
Money rules the worldBaas, Paul / van Meerbeeck, Jan et al. | 2016
- 79
-
Costs of non-small cell lung cancer in the Netherlandsvan der Linden, N. / Bongers, M.L. / Coupé, V.M.H. / Smit, E.F. / Groen, H.J.M. / Welling, A. / Schramel, F.M.N.H. / Uyl-de Groot, C.A. et al. | 2016
- S2
-
5 A novel microRNA signature associated with cisplatin resistant NSCLC holds both diagnostic and prognostic biomarker potentialMacDonagh, L. / Gray, S.G. / Cuffe, S. / Finn, S.P. / Young, V. / Ryan, R. / Nicholson, S. / Leonard, N. / Yin Sui, J. Sze / O'Byrne, K.J. et al. | 2016
- S3
-
8 Exploitation of the vitamin A/retinoic acid axis in the re-sensitisation of cisplatin resistant NSCLC cellsMacDonagh, L. / Gray, S.G. / Cuffe, S. / Finn, S.P. / O'Byrne, K.J. / Barr, M.P. et al. | 2016
- S4
-
11 The switch to invasiveness in lung adenocarcinomaMoore, D.A. / Rehal, P. / Swanton, C. / Le Quesne, J. et al. | 2016
- S5
-
14 Phagocytic behaviour in lung adenocarcinoma cells: clinical implications and cellular mechanismsMackay, H.L. / Moore, D.A. / Muller, P. / Le Quesne, J. et al. | 2016
- S6
-
17 A case of EGFR exon 20 mutation treated with erlotinibSpiliopoulou, P. / Steele, N. et al. | 2016
- S8
-
23 Characteristics of lung cancer patients diagnosed following emergency admissionRuparel, M. / Ejaz, A. / Chauhan, N. / Ridge, M. / Chung, D. / Succony, L. / Banka, R. / Thakrar, R. / Kumar, N. / Sage, E. et al. | 2016
- S10
-
29 Lung cancer diagnostic pathway from date of abnormal chest X-ray to treatmentKhan, S. Leyakathali / Barker, D. / Hussain, I. / Maddekar, N. et al. | 2016
- S11
-
31 Outcomes following the implementation of British Thoracic Society Nodule Guidelines through a formal multidisciplinary team process – a district general hospital experienceBudd, R. / Yamani, Q. / Stannard, P. / Kyi, M. et al. | 2016
- S13
-
37 Is it all in the head? The value of performing a CT brain in staging patients with non-small cell lung cancer (NSCLCa)Morrison, K.A. / Lord, H. et al. | 2016
- S14
-
40 Are we staging N2 disease in non-small cell lung cancer as accurately as possible? The NHS Tayside experienceHart, J. / Lord, H. et al. | 2016
- S15
-
43 Quality standards for invasive tests for diagnosis and staging of lung carcinoma: a retrospective review at a tertiary referral hospitalHobbins, S. / Woolhouse, I. et al. | 2016
- S16
-
46 PRImary versus Metastasis using Iontorrent Next Generation Sequencing (PRIMINGS)Moore, D.A. / Martinson, L. / Dalleywater, W. / Shaw, J. / Le Quesne, J. et al. | 2016
- S17
-
49 Increasing incidence of non-smoking lung cancer: presentation of patients with early disease to a tertiary institution in the UKCufari, M.E. / Proli, C. / Phull, M. / Nicholson, A. / Al-Sahaf, M. / Raubenheimer, H. / Asadi, N. / Perikleous, P. / Jordan, S. / Dusmet, M. et al. | 2016
- S18
-
52 Ultrasound guided fine needle aspiration (FNA) of supraclavicular neck nodes in patients with suspected lung cancer – a retrospective review of practice in North Devon district hospitalMitchell, T. / Elsaddig, A. / Davies, J. / Meller, M. et al. | 2016
- S20
-
56 Efficacy and safety of brigatinib (AP26113) in ALK+ NSCLC: phase 1/2 trial resultsGettinger, S.N. / Bazhenova, L.A. / Salgia, R. / Langer, C.J. / Gold, K. / Rosell, R. / Shaw, A.T. / Weiss, G.J. / Dorer, D.J. / Rivera, V.M. et al. | 2016
- S21
-
58 Crizotinib toxicity, dose adjustments and initial response: a single centre experienceArunsingh, M. / Shrimali, R. / Dabkara, D. / Biswas, B. / Midha, D. / Parihar, M. / Mukherjee, G. / Mishra, D. / Chatterjee, S. et al. | 2016
- S22
-
61 Factors affecting sensitising EGFR mutation rate and cell type in stage IIIB/IV lung cancerKennedy, M.P.T. / Quinn, J.A. / Biswas, A.R. / Rothwell, A.E.J. / Scally, A. / Cheyne, L. / Callister, M.E.J. et al. | 2016
- S23
-
65 Erlotinib: how good is it in a Scottish population?Gallanagh, M. / Lord, H. et al. | 2016
- S24
-
68 An audit of the use of first-line EGFR TKI treatment in NSCLC patients with EGFR activating mutations at the York Teaching Hospitals and Harrogate and District NHS Foundation TrustBhagawati-Prasad, V. / Aspden, E. / Chan, S. / Darby, A. et al. | 2016
- S25
-
70 Heterogeneity of programmed death-ligand 1 expression in multifocal lung cancerMansfield, A.S. / Murphy, S. / Peikert, T. / Yi, J. / Vasmatzis, G. / Wigle, D. / Aubry, M.C. et al. | 2016
- S26
-
73 “Switch Maintenance” chemotherapy with pemetrexed after carboplatin and vinorelbine in advanced NSCLCDavies, R. / Maguire, J. et al. | 2016
- S27
-
76 Outcomes and tolerability of second line treatment for non small cell lung cancer (NSCLC)Salih, Z. / Conway, A.M. / Bayman, N. / Blackhall, F. / Califano, R. / Harris, M. / Lee, L. / Sheikh, H. / Taylor, P. / Summers, Y. et al. | 2016
- S29
-
82 Accrual to clinical trials – an updatePlant, R.E. / Chauhan, M. / Nelson, L. / Fennell, D. / Ahmed, S.I. et al. | 2016
- S30
-
85 What are the commonest toxicities for patients receiving chemotherapy for NSCLC? – a look at 6 months of data for all comersAllison, J.L.E. / Lord, H. et al. | 2016
- S31
-
87 Mesothelin-targeted immunotherapy CRS-207 plus chemotherapy as treatment for malignant pleural mesothelioma (MPM)Hassan, R. / Alley, E. / Kindler, H. / Antonia, S. / Jahan, T. / Grous, J. / Honarmand, S. / Mcdougall, K. / Whiting, C. / Nair, N. et al. | 2016
- S32
-
90 Accrual to clinical trials in mesotheliomaPlant, R.E. / Chauhan, M. / Nelson, L. / Fennell, D. / Ahmed, S.I. et al. | 2016
- S35
-
99 A framework to support the lung cancer nurse specialist in the development and evaluation of nurse-led clinicsMorgan, S. / Draffan, J. / Bolton, S. / Borthwick, D. / Field, S. / Morley, J. / Rees, P. / Roberts, J. / Savory, S. / Thomas, C. et al. | 2016
- S36
-
102 Lung cancer in Ireland 2010–2015 – are we making progress?McNamara, A. et al. | 2016
- S38
-
108 Healthcare costs associated with lung cancer diagnosed at emergency hospitalisationKennedy, M.P.T. / Hall, P.S. / Callister, M.E.J. et al. | 2016
- S39
-
111 Why involve consumers in cancer research?Rawlinson, J. et al. | 2016
- S40
-
114 Use of routine healthcare data for the estimation of disease outcomes in locally advanced non-small cell lung cancer (LA NSCLC)Wong, S. / Ricketts, K. / Royle, G. / Mendes, R. et al. | 2016
- S42
-
119 Treatment outcomes in stage I lung cancerKennedy, M.P.T. / Lummis, K.L. / Spencer, K. / Snee, M. / Franks, K. / Callister, M.E.J. et al. | 2016
- S43
-
121 Continuous hyperfractionated accelerated radiotherapy (CHART) using volumetric modulated arc therapy (VMAT) for locally advanced non-small cell lung cancer (NSCLC) – the clinical experienceShrimali, R. / Sen, P. / Arunsingh, M. / Mahata, A. / Mallick, I. / Prasath, S. / Achari, R. / Chatterjee, S. et al. | 2016
- S46
-
129 An audit of a single center use of SABR in primary lung cancer patientsLohnson, K.A. / Rahman, S.U. / Sridhar, T. / Savory, S. / Aznar-Garcia, L. et al. | 2016
- S47
-
131 Preliminary results of prospective data for patients receiving stereotactic ablative radiotherapy (SABR) for early stage non-small cell lung cancer (NSCLC)Pickles, R.L. / Iqbal, S. / Atherton, P. / Turnbull, H. / Mcmenemin, R. / Walker, C. / Pilling, K. / Muller, M. / Mott, J. / Mccallum, H. et al. | 2016
- S48
-
133 SABR for lung cancer – a case for development of a service in TaysidePonnusamy, S. / Brown, E. et al. | 2016
- S49
-
136 Electronic patient reported outcomes significantly improved toxicity data collection and were acceptable to both patients and clinicians in lung cancer radiotherapy outpatient clinicsShears, A. / Bayman, N. / Harris, M. / Lee, L. / Haslett, K. / Wilson, B. / Faivre-Finn, C. et al. | 2016
- S50
-
139 A retrospective review of lung cancer patients receiving whole brain radiotherapy treated at the Kent Oncology Centre (KOC) in 2014, audited against the QUARTZ trialHegarty, G. / Turner, J.Y. / Sevitt, T. / Burcombe, R. / Cominos, M. / Taylor, H. / Beesley, S. / Hadaki, M. / Shah, R. / Mikropoulos, C. et al. | 2016
- S51
-
142 Dosimetric findings in patients with moderate to severe late toxicity following SABR for lung cancerAznar-Garcia, L. / Johnson, K.A. / Morenc, A. / Sridhar, T. et al. | 2016
- S52
-
144 Audit of palliative whole brain radiotherapy (WBRT) in patients with non-small cell lung cancer (NSCLC) treated at the Oxford Cancer Centre over 2½ yearsShakir, R. / Buffa, F. / Higgins, G. / Horne, A. / Stuart, R. / Vallis, K. / Panakis, N. et al. | 2016
- S53
-
147 Palliative thoracic radiotherapy in locally advanced/metastatic non-small cell lung cancer (NSCLC)Maclennan, K. / Campbell, S. / Little, F. / Erridge, S. / Evans, T. / Price, A. et al. | 2016
- S54
-
150 Ninety-day mortality following radical radiotherapy for lung cancerNolan, E. / Pemberton, L. / Coote, J. / Harris, M. / Lee, L. / Faivre-Finn, C. / Sheikh, H. / O'Hara, C. / Burt, P. / Bayman, N. et al. | 2016
- S56
-
155 Should we be more aggressive in treating patients with small cell lung cancer?Lim, J. / Skailes, G. / Fyfe, D. et al. | 2016
- S57
-
157 Comparison of outcomes for early small cell lung cancer (SCLC) treated with surgery versus concurrent chemo radiation (CTRT)Foy, V. / Cree, A. / Nawaz, M. / Faivre-Finn, C. / Bayman, N. / Sheikh, H. / Taylor, P. / Blackhall, F. / Jones, M.T. / Krysiak, P. et al. | 2016
- S58
-
160 PCI – improving on a parallel pairSmith, D. / Thomas, C. / Denyer, E. / Sawyer, E. / Swampillai, A. / Ahmad, S. et al. | 2016
- S60
-
167 The Hillingdon Hospital NHS Trust Test community case study – adult cancer survivorship programme: tumour group lungLynch, J. / Lemon, C. / Pike, L. / Walker, J. et al. | 2016
- S61
-
170 The role of cryotherapy for obstructive, tracheobronchial lesions: a reviewBeeson, J. / Austin, J. / Maiwand, O. / Anikin, V. et al. | 2016
- S62
-
173 Early chest mechanics changes post lung cancer resection: the effect of thoracic nerve blocksElshafie, G. / Steyn, R. / Kalkat, M. / Bishay, E. / Rajesh, P. / Naidu, B. et al. | 2016
- S63
-
176 Carcinoid lung cancer: 4-year data of patients treated in a tertiary centreAsa'Ari, K. Abi Musa / Haris, M. / Satur, C. / Abid, Q. / Ghosh, S. / Khan, S. Leyakathali et al. | 2016
- S64
-
179 Predictors of mortality in thoracic surgery for high risk patients with lung cancerAl-Najjar, H. / Foden, P. / Shah, R. / Crosbie, P. / Booton, R. / Evison, M. et al. | 2016
- S65
-
181 Comparison of outcomes of sleeve lobectomy for lung carcinoid versus non-small cell lung cancerLang, P. / Singh, S. / Murray, J. / Kirk, A. et al. | 2016
- S66
-
184 The benefits of pneumonectomy avoidance through broncho-angioplastic techniques for main stem non-small cell lung cancers (NSCLC)Paik, A. / Bilancia, R. / Waller, D. et al. | 2016
- S67
-
187 Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC trialTreasure, T. et al. | 2016
- S68
-
189 VIdeo assisted thoracoscopic lobectomy versus conventional Open LobEcTomy for lung cancer, a multi-centre randomised controlled trial with an internal pilot: the VIOLET studyLim, E. / Brush, T. / Rogers, C. et al. | 2016
- S69
-
191 Isotoxic intensity modulated radiotherapy (IMRT) in stage III non small cell lung cancer (NSCLC) – a feasibility studyGroom, N. / Tsang, Y. / Hatton, M. / Hanna, G.G. / Franks, K. / Harden, S. / Mcdonald, F. / Harrow, S. / Faivre-Finn, C. et al. | 2016
- S70
-
193 PIT: a phase III trial of Prophylactic Irradiation of Tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionBayman, N. / Ardron, D. / Ashcroft, L. / Baldwin, D. / Booton, R. / Darlison, L. / Edwards, J.G. / Lang-Lazdunski, L. / Lester, J.F. / Peake, M. et al. | 2016
- S73
-
Author Index| 2016
- v
-
Contents| 2016
-
93 The identification and appreciation of the specific needs of lung cancer patients receiving surgery and adjuvant chemotherapyPeplow, K. / Watts, J. / Beanland, L. / Stavrinos, P. et al. | 2016
-
18 Non-small cell lung cancer (NSCLC) and longitudinally extensive transverse myelitis (LETM): is surgical risk worthwhile? A case reportAntonopoulos, A. / Jonck, E. / Gregoriou, A. / Spencer, E. / Tenconi, S. et al. | 2016
-
35 Changing patterns of hospital admissions for lung cancer patients in Ireland, 2005 to 2014Quintyne, K.I. / Mccarthy, T. / Murray, D. / Morgan, R. / Mannix, M. et al. | 2016
-
26 Access to radical treatment for patients with non-small cell lung cancerEccles, A. / Magee, N.D. / Warke, T.J. et al. | 2016
-
125 Planning study comparing the use of photon radiation therapy to proton therapy for superior sulcus tumours (SSTs)Wong, S. / Alshaikhi, J. / Lalli, N. / Bhudia, P. / D'Souza, D. / Amos, R. / Royle, G. / Mendes, R. et al. | 2016
-
180 Cardiothoracic surgeons can provide a safe and effective thoracic surgery serviceRajnish, R.K. / Richards, R. / Bittar, M. / Duncan, A. / Purohit, M. / Zacharias, J. et al. | 2016
-
96 Building international oncology nurse collaborations to improve thoracic oncology patient careGuerin, M. / Culligan, M. / Borthwick, D. / Broderick, C. / Darlison, L. / Duffy, M. / Ivimey, B. / Hesdorffer, M. / Mcphelim, J. et al. | 2016
-
53 A review of a thoracoscopy serviceAujayeb, A. / Mackenzie, J. / Cooper, D. / Parker, S. / Miller, J. / Bourke, S. et al. | 2016
-
9 EGFR and EML4-Alk testing for non-small cell lung cancer patients – a single centre experienceChatterjee, S. / Arora, N. / Parihar, M. / Midha, D. / Mukherjee, G. / Dabkara, D. / Biswas, B. / Mishra, D. / Shrimali, R. et al. | 2016
-
66 Promoting awareness and improving education to more effectively manage toxicity of EGFR TKI medication; information for patients and primary care physiciansRush, H. / Thomas, R. / Vick, J. / Lacy, K. / Lal, R. et al. | 2016
-
143 Survey of UK practice of palliative radiotherapy post chemotherapy in stage 4 NSCLCLee, C.E. / Tathagata, D. / Hatton, M. et al. | 2016
-
151 The incidence of thoracic re-irradiation at 3 UK cancer centres following curative intent radiotherapy for non-small cell lung cancerScobie, S. / Hanna, G.G. / Franks, K. / Mcaleese, J. / Harrow, S. et al. | 2016
-
91 The effect of benign and malignant pleural disease on chest wall mechanicsElshafie, G. / Kalkat, M. / Steyn, R. / Bishay, E. / Rajesh, P. / Naidu, B. et al. | 2016
-
94 Roy Castle Lung Cancer Foundation: making the case for LCNSsFox, J. / Mcpherson, C. / Parker, V. et al. | 2016
-
79 Re-audit of cisplatin (>70 mg/m2) induced nausea and vomiting, following the introduction of aprepitantMack, E. / Campbell, L. / Scullin, P. et al. | 2016
-
105 Patient journey interviews: a tool for service improvement in thoracic surgeryDixon, S. / White, J. et al. | 2016
-
75 Palliative second-line systemic treatment of non-small cell lung cancer within a UK cancer centreStokoe, I.M. / Tuthill, M. / Balakrishnan, L. / Brock, J.E. et al. | 2016
-
194 SYSTEMS-2: a randomised phase II trial of standard versus dose escalated radiotherapy in the treatment of pain in malignant pleural mesotheliomaAshton, M. / O'Rourke, N. / Macleod, N. / Chalmers, A. et al. | 2016
-
171 Early chest mechanics changes post lung cancer resection: the effect of post operative pulmonary complications on chest wall mechanicsElshafie, G. / Steyn, R. / Bishay, E. / Kalkat, M. / Rajesh, P. / Naidu, B. et al. | 2016
-
13 Creation of a large single-centre retrospective tumour archiveDas, M. / Moore, D.A. / Sereno, M. / Smith, C. / Hastings, R. / Le Quesne, J. et al. | 2016
-
80 Can we give SACT to patients with NSCLC on time and at full dose?Allison, J.L.E. / Lord, H. et al. | 2016
-
32 An evaluation of presenting symptoms in patients referred via the two week wait (2WW) pathway to the chest clinic in a UK district general hospitalReddy, R. / Jackson, M. / Myerson, J. / Elkins, A. / Al Rifai, M. Saey et al. | 2016
-
95 Evaluation of the lung cancer nurse specialist communication workshopDe Normanville, C. / Turner, J. / Ibbotson, R. / Harrop, D. et al. | 2016
-
67 Aggressive and unusual metastatic relapses in resected epidermal growth factor receptor (EGFR) mutant adenocarcinoma of lung: biology or chance occurrence?Aslam, S. / Jessop, S. / Jeffs, Y. / Bulusu, V. et al. | 2016
-
100 Singing for breathing: a community based intervention for chronic respiratory diseasesEastwood, C. / Ellis, A. et al. | 2016
-
98 Outcomes from a novel nurse led telephone clinic, post-thoracic surgeryLove, J. / Moore, A. / Hyde, A. / Berwick, S. / Thomas, R. et al. | 2016
-
112 Spreading the word – using consumers effectivelyRawlinson, J. et al. | 2016
-
182 Patient satisfaction with quality of information in lung cancer surgeryOswald, N. / Hardman, J. / Kerr, A. / Webb, J. / Bellamy, M. / Steyn, R. / Bishay, E. / Rajesh, P. / Kalkat, M. / Naidu, B. et al. | 2016
-
186 Using electronic patient records as an effective tool to screen and improve recruitment to a Phase 1 trial in non-small cell lung cancerHaslett, K. / Ashcroft, L. / Bramley, R. / Wilson, B. / Livsey, J. / Asselin, M. / Bayman, N. / Burt, P. / Chan, C. / Coote, J. et al. | 2016
-
118 Smoking habits in lung cancer patients and their carers and audit of smoking advice givenPankhania, D. / Coote, J. / Burt, P. / Mackereth, P. / Finchett, C. / Orrett, L. / Hodgson, C. / Bayman, N. / Blackhall, F. / Califano, R. et al. | 2016
-
57 Crizotinib in clinical practice: the North East of England's experienceHall, S. / Lambourne, B. / Aynsley, E. / Gardiner, J. / Greystoke, A. / Hughes, A. / Jones, C. / Leaning, D. / Li, L. / Mansy, T. et al. | 2016
-
2 Detecting and monitoring somatic mutations in circulating cell free tumour DNA in patients with lung cancerNelmes, D.J. / Williams, A.S. / Button, M.R. / Lester, J.F. / Butler, R. / Chester, J. et al. | 2016
-
124 Dosimetric evaluation of adaptive planning during radiotherapy (ART) in radical lung to ensure tumour coverage and/or minimise doses to organs at risk – case discussionMorenc, A. / Johnson, K.A. / Sridhar, T. / Ahmed, S.I. / Aznar-Garcia, L. et al. | 2016
-
122 To determine ideal gross tumour volumes and PTV expansion using four-dimensional computed tomography for the treatment of lung cancerGoyal, N. / Ingle, M. / Bhuva, N. / Power, D. / Lewanski, C. et al. | 2016
-
148 Lung toxicity and patient outcomes correlated to V5, V20, lung and PTV volume in patients treated radically for non-small cell lung cancer at the Beatson West of Scotland Cancer CentreHarrand, R. / Smith, S. / Flanagan, Y. et al. | 2016
-
19 Can oral methotrexate improve survival in mesothelioma? Case reportRizvi, S.A.J. / Shariar, R. / Eldeeb, H. et al. | 2016
-
62 Abstract withdrawn.| 2016
-
106 Evaluation of quality of life in patients with primary and metastatic lung cancer following radiofrequency ablationBeeson, J. / Anikin, V. / Dalal, P. et al. | 2016
-
123 Breath-hold technique during radical radiotherapy for non-small-cell lung cancer (NSCLC)Hollingdale, A.E. / Orchard, E.J. / Treece, S.J. et al. | 2016
-
174 An audit of relapse rate in early stage non-small cell lung cancer treated with surgical resectionWoolcock, S. / Quinn, R. / Pollock, S. / Chamberlin, N. / Kersbergen, J. / Murphy, S. / Sridharan, K. / Stamenkovic, S. / Taylor, I. et al. | 2016
-
47 Completion of the clinical audit cycle for delivery of molecular testing service for patients with non-small-cell lung cancer referred to the Royal MarsdenKordbacheh, T. / Kumar, R. / Biondo, A. / Tan, R. / Yap, T. / Popat, S. / Bhosle, J. / O'Brien, M.E. et al. | 2016
-
74 A prospective audit on toxicity and clinical outcomes for platinum-based chemotherapy in stage IIIB/IV non-small cell lung cancer (NSCLC): a West of Scotland analysisAli, C. / Kumari, M. / Mcphelim, J. / Maclean, F. / Cadwallader, S. / Hicks, J. et al. | 2016
-
71 Statins as novel therapeutic agents in targeting TAMs within human NSCLC microenvironmentAldujaily, E.A. / Kamata, T. / Moore, D.A. / Le Quesne, J. / Pritchard, C. et al. | 2016
-
39 Endobronchial ultrasound – a review of this novel service in Altnagelvin HospitalMoore, I. / Kelly, M.G. et al. | 2016
-
159 A retrospective audit to assess compliance with current national guidelines on management of small cell lung cancer and analysis of patient outcomeColley, J. / Lee, R. / Crews, W. et al. | 2016
-
63 Afatinib in non-small cell lung cancerWood, G.E. / Polychronis, A. et al. | 2016
-
30 Patient experience of a telephone nodule follow-up clinicRoss, C.L. / Psallidas, I. / Moore, A.J. / Sykes, A. et al. | 2016
-
92 Final diagnosis for patients referred to pleural clinicMackenzie, J. / Conroy, K. / De, P. et al. | 2016
-
69 Afatinib versus gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC) harbouring activating EGFR mutations: results of the global, randomised, open-label, phase IIb trial LUX-Lung 7O'Byrne, K.J. / Park, K. / Tan, E. / Zhang, L. / Hirsh, V. / Boyer, M. / Yang, J.C. / Mok, T. / Kim, M. / Massey, D. et al. | 2016
-
116 Gene mutation profile of non-smokers compared to smokers participating in the CRUK stratified medicines programme at a single institutionDe Sousa, P. / Barbosa, M. / Cufari, M.E. / Proli, C. / Azcarate, L. / Raubenheimer, H. / Leung, M. / Rice, A. / Fernandez, A. Montero / Robertus, J.L. et al. | 2016
-
183 Can 30 day-mortality after lung cancer resection be used as an individual surgeon quality outcome? National data from the United KingdomProli, C. / Cufari, M.E. / Raubenheimer, H. / Al-Sahaf, M. / Shedden, L. / Luciano, G. / Perikleous, P. / Asadi, N. / Chavan, H. / Meza-Guzman, M. et al. | 2016
-
175 Pneumonectomy for lung cancer: long-term outcome of 15-year experience of a single centerHussain, A. / Qadri, S. / Haqzad, Y. / Chaudhry, M. / Cale, A. / Cowen, M. / Loubani, M. et al. | 2016
-
115 Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancerMansfield, A.S. / Tafur, A.J. / Kourelis, T.V. / Wysokinska, E.M. / Yang, P. et al. | 2016
-
50 Is the development of primary lung adenocarcinoma simply due to “bad luck”?Cufari, M.E. / Proli, C. / Phull, M. / Raubenheimer, H. / Al-Sahaf, M. / Nicholson, A. / Viola, P. / Asadi, N. / Perikleous, P. / Jordan, S. et al. | 2016
-
7 Cancer stem cells: targeting aldehyde dehydrogenase 1 (ALDH1) as a novel strategy to overcome cisplatin resistance in NSCLCMacDonagh, L. / Gray, S.G. / Cuffe, S. / Finn, S.P. / O'Byrne, K.J. / Barr, M.P. et al. | 2016
-
59 Management of ALK rearranged non-small cell lung cancer (NSCLC) diagnosed at the Leeds Cancer Centre between 2013 and 2015Sun, F. / Hewitt, V. / Dickinson, H. / Mulatero, C. et al. | 2016
-
81 Audit of 1 year survival for patients receiving chemotherapy for NSCLC – all comersAllison, J.L.E. / Lord, H. et al. | 2016
-
153 Small cell lung cancer – an email alert system to reduce time to first treatmentNicholas, O.J. / Mallett, C.L. / Frazer, R.D. / Rowley, K. et al. | 2016
-
132 Is stereotactic ablative radiotherapy (SABR) a safe treatment for multiple primary lung cancer (MPLC) non-small cell lung cancer (NSCLC)?Murray, P.F. / Spencer, K. / Snee, M. / Dickinson, P. / Jain, P. / Clarke, K. / Franks, K. et al. | 2016
-
41 Patient satisfaction during bronchoscopy and endobronchial ultrasound performed under conscious sedationTufail, M. / Singh, M. / Butt, H. / Bennett, J. / Panchal, R. et al. | 2016
-
101 Crossing the boundaries with proactive care for lung cancer patients – developing and testing a new model of careWells, L.M. / Reece, J. / Summers, E. / Gore, A. / Nasimudeen, A. et al. | 2016
-
78 Denosumab in lung cancerWright, F.A. / Plant, R.E. / Goyal, U. / Ahmed, S.I. et al. | 2016
-
138 Stage I non small cell lung cancer (NSCLC): single centre comparison of outcome by treatment with surgery, conventional radiotherapy and stereotactic ablative radiotherapyThippu Jayaprakash, K. / Gilligan, D. / Harden, S. et al. | 2016
-
152 The feasibility of conducting radiotherapy trials in patients with stage II–III non-small cell lung cancer (NSCLC) not eligible for chemotherapy and/or surgery: results of a clinical audit over an 18-month periodSalem, A. / Faivre-Finn, C. et al. | 2016
-
163 A randomised study comparing the effectiveness of acupuncture (A) or morphine (M) versus the combination (AM) for the relief of dyspnoea in patients with advanced non small cell lung cancer and mesotheliomaMinchom, A.R. / Punwani, R. / Filshie, J. / Bhosle, J. / Nimako, K. / Gunapala, R. / Popat, S. / O'Brien, M.E. et al. | 2016
-
6 Cisplatin induces the emergence and expansion of a distinct cancer stem cell (CSC) population in NSCLCMacDonagh, L. / Gray, S.G. / Cuffe, S. / Finn, S.P. / Young, V. / Ryan, R. / Nicholson, S. / Leonard, N. / O'Byrne, K.J. / Barr, M.P. et al. | 2016
-
4 Identification and targeting of the DNA repair gene, XRCC6BP1, in cisplatin resistant NSCLCBarr, M.P. / Foley, E. / He, Y. / Young, V. / Ryan, R. / Nicholson, S. / Leonard, N. / O'Byrne, K.J. / Finn, S.P. / Cuffe, S. et al. | 2016
-
Editorial Board| 2016
-
28 Where and why do patients with advanced lung cancer present in Wolverhampton?Hancock, J. / Tanner, K. / Roden, K. / Morgan, A. et al. | 2016
-
126 CyberKnife® for early stage non-small cell lung cancer (NSCLC) at a tertiary referral centre – results of the first two years of treatment at BirminghamSangha, V. / Stevenson, R. / Harrop, V. / Heyes, G. / Howard, H. / Kapadia, A. / Ghafoor, Q. et al. | 2016
-
109 Development of a new online map to review standards of lung cancer services in the UKTownsend, C.N. / Woodley, G. et al. | 2016
-
21 Abstract withdrawn.| 2016
-
48 Do stage I lung cancer patients have lung cancer symptoms?Higgins, E.M. / Rees, T. / Lester, J.F. / Davies, R.S. et al. | 2016
-
33 Patient reported experience measures in improving rapid access lung cancer clinic holistic care outcomesTang, H.K.C. / Rees, J. / Collier, G. et al. | 2016
-
107 Performance status, not age, influences decision-to-treat in non small cell lung cancer (NSCLC)Mactier, K. / Bonner, J. / Suthermaraj, G. / Greystoke, A. et al. | 2016
-
24 The impact of an inpatient acute oncology service on new lung cancer diagnosesAyub, S. / Law, A. / Sridhar, T. / Aznar-Garcia, L. / Fennell, D. / Ahmed, S.I. et al. | 2016
-
27 Talc pleurodesis via chest drain vs indwelling pleural catheter (IPC) for managing malignant pleural effusions in a district general hospitalAdizie, J.B. / Harrison, S. / Huntley, C. / Sivakumar, N. / Morgan, A. et al. | 2016
-
162 Uptake of prophylactic cranial irradiation in patients with small cell lung cancer within the Mount Vernon Cancer NetworkTharmalingam, H. / Oliver, T. / Reid, E. / Mir, R. / Denton, A. / Mawdsley, S. / Moule, R. / Polychronis, A. / Dickson, J. et al. | 2016
-
83 Management of stage 4 NSCLC patients with performance status of 2Patterson, D.M. et al. | 2016
-
156 Outcomes after surgery for small cell lung cancer in the West of ScotlandHanna, C. / Maclaren, V. / Featherstone, C. et al. | 2016
-
38 Brain imaging before lung cancer resection? An analysis of data from BristolHudson, Z. / Holdway, M. / Addeo, A. et al. | 2016
-
185 Surgical resection of lung cancer patients referred from district general hospital – our experienceMehdi, S.B. / Su, K. / Mcdermott, S. / Shah, R. / Sundar, R. et al. | 2016
-
165 Pleural service in a district general hospitalConroy, K. / Mackenzie, J. / De, P. et al. | 2016
-
190 Testing the feasibility of establishing a cohort of lung cancer patients to investigate recovery following radiotherapy with curative intentCalman, L. / Richardson, A. / Smith, P. / Baird, J. / Edwards, J.G. / Faivre-Finn, C. / Foster, C. et al. | 2016
-
164 A review of an indwelling pleural catheter serviceAujayeb, A. / Cooper, D. / Mackenzie, J. / Parker, S. / Miller, J. / Bourke, S. et al. | 2016
-
158 Management of small cell lung cancer in Manchester's Northwest SectorMehdi, S.B. / Jeyarajah, C. / Storrar, J. / Craig, C. / Orekoya, O. / Obot, I. / Shah, D. / Halkyard, E. / Webster, I. / Sheikh, H. et al. | 2016
-
55 The introduction of the Cancer Research UK Stratified Medicine Programme 2 (CRUK SMP2) in North East England; lessons learned and experience gainedGreystoke, A. / Hogarth, L. / Patterson, M. / Williams, I. / Ness, T. / Georgiadis, K. / Bolt, L. / Bettison, I. / Turner, D. / Jamieson, D. et al. | 2016
-
10 Multiplex genotyping of matched EBUS TBNA and cfDNA samples in advanced NSCLC patientsLyons, J. / O'Brien, C. / Krussel, S. / Finn, S.P. / Cuffe, S. / O'Connell, F. / Gately, K. et al. | 2016
-
128 A study comparing lung SABR plans generated using Multiplan for CyberKnife and Monaco for Elekta Versa 6FFFDalling, K. / Ghafoor, Q. / Watkins, S. / Jackson, T. et al. | 2016
-
140 Outcomes of salvage radiotherapy in the treatment of NSCLC with loco-regional relapseCalisaya, P. / Johnston, R. / Mcaleese, J. / Eakin, R. / Hanna, G.G. et al. | 2016
-
42 Determinants of intra-procedure hypoxia during EBUS for cancerSmyth, R. / Brennan, V. / Breen, D. et al. | 2016
-
104 The LEAD programme: a novel approach to continuing professional development for lung cancer nurse specialistsBorthwick, D. / Guerin, M. / Horne, N. / Pascoe, S. / Smith, S. / Wakelin, S. et al. | 2016
-
60 Afatinib in EGFR mutation positive advanced non-small cell lung cancerDavies, R.S. / Brewster, A.E. / Button, M.R. / Lester, J.F. et al. | 2016
-
54 ALK translocated NSCLC in the West of Scotland: the first 18 monthsMukherjee, L. / Williams, N. / Dick, C. / Kennedy, A. / Steele, N. et al. | 2016
-
22 Pneumoperitoneum following CT guided percutaneous lung biopsyAli, H. / Raza, A. / Khan, S. Leyakathali / Maddekar, N. et al. | 2016
-
84 30 day mortality following systemic anti-cancer treatment (SACT) in lung cancer: experience from a cancer unitJessop, S. / Sillah, T. / Jeffs, Y. / Aslam, S. / Bulusu, V. et al. | 2016
-
16 A surprise at the end of the scope – non-Hodgkin's B-cell lymphoma presenting as a solitary endobronchial lesion – a rare and unusual presentationTerrington, D. / Tabbara, R. / Craig-Mcquaide, A. / Pawlowicz, A. et al. | 2016
-
110 Geographical disparities in access to lung cancer services in EnglandMurage, P. / Crawford, M. / Bachmann, M. / Jones, A. et al. | 2016
-
88 Global estimation of mesothelioma deathsChimed-Ochir, O. / Takahashi, K. / Yoko-O, M. / Takala, J. et al. | 2016
-
103 BREATHE (Breath, Rehabilitation, Exercise And Transforming Health Education) – a cancer survivor initiative program at University College London HospitalGauntlett, S. / Mcarsey, D. / Lough, F. / Mendes, R. et al. | 2016
-
130 Stereotactic ablative body radiotherapy (SABR): Weston Park Hospital experienceDas, T.S. / Bates, E. / Waweru, A. / Fisher, P. / Lee, C.E. / Hatton, M. et al. | 2016
-
141 HALT trial: stereotactic radiotherapy for oligo-progressive disease (OPD) in oncogene-addicted lung tumours – results of a national trial feasibility questionnaireBainbridge, H. / Toms, C. / Kilburn, L. / Popat, S. / Bliss, J. / Mcdonald, F. et al. | 2016
-
188 ADSCaN: a randomised phase II study of Accelerated, Dose escalated, Sequential, Chemo-radiotherapy in Non-Small Cell Lung CancerLandau, D. / Faivre-Finn, C. / Lester, J.F. / Maguire, J. / Paul, J. / Mccartney, E. / Haswell, T. / Boyd, K. / Fenwick, J. / Parsons, E. et al. | 2016
-
166 Audit on the characteristics of lung cancer patients who receive BSC (best supportive care)Harris, M. / Hanna, D. / Faivre-Finn, C. / Bayman, N. / Chittalia, A. / Stout, R. / Pemberton, L. / Califano, R. / Burt, P. / Blackhall, F. et al. | 2016
-
1 A comparative analysis of cancer hotspot mutation profiles in circulating tumour cells, circulating tumour DNA and matched primary lung tumourLeung, M. / Freidina, D. / Nicholson, A. / Rice, A. / Freidin, M. / Fernandez, A. Montero / Popat, S. / Lim, E. et al. | 2016
-
146 Retrospective audit of treatment outcomes from palliative thoracic radiotherapy – a single centre experienceAladili, Z. / Kearns, D.J. / Chan, O. et al. | 2016
-
135 Multiple training interventions significantly improves PET/CT based lung cancer radiotherapy target volume delineation following an IAEA based delineation protocolKonert, T. / Vogel, W. / Macmanus, M. / Everitt, S. / Thorwarth, D. / Sonke, J. / Fidarova, E. / Paez, D. / Hanna, G.G. et al. | 2016
-
145 Documentation of DVLA guidance provision for patients with brain metastasesPatel, P. / Welsh, L. / Hopkins, N. / Mcdonald, F. et al. | 2016
-
177 The effect of lung cancer resection on chest wall mechanics of COPD patientsElshafie, G. / Kalkat, M. / Steyn, R. / Bishay, E. / Rajesh, P. / Naidu, B. et al. | 2016
-
45 “PAXgene Tissue” – a novel alternative to formalin fixation for diagnostic pathologySouthwood, M. / Rassl, D. et al. | 2016
-
161 Outcomes of concurrent chemoradiotherapy in small cell lung cancerMccann, B. / Harrow, S. et al. | 2016
-
134 Long term local tumour control in inoperable NSCLC treated with accelerated hypofractionated radiotherapy and concurrent cisplatinum and vinorelbineKelly, V. / Maguire, J. et al. | 2016
-
15 A rational organotypic model of human bronchial dysplasiaCorreia, L. / Littlewood, T. / Evan, G. / Mccaughan, F. et al. | 2016
-
89 Experience of the treatment of malignant mesothelioma at a UK centrePlant, R.E. / Chauhan, M. / Wright, F.A. / Darlison, L. / Porter, S. / Fennell, D. / Ahmed, S.I. et al. | 2016
-
168 Multidisciplinary follow up of patients with advanced lung cancerSaunders, Y. / Lynch, J. / Pike, L. / Dickson, J. et al. | 2016
-
117 Electronic cigarettes: a survey of observed patient use and attitudes among members of the British Thoracic Oncology GroupSherratt, F.C. / Newson, L. / Field, J.K. et al. | 2016
-
172 A national survey of thoracic surgery units: pre-operative smoking cessation practice shows need for better provision of serviceOswald, N. / Konda, N. / Kerr, A. / Naidu, B. / Thickett, D. / Webb, J. / Dancer, R. et al. | 2016
-
72 The Royal Marsden NHS Foundation Trust experience of maintenance pemetrexed following first-line cisplatin/pemetrexed in advanced non-squamous lung cancerDumas, L. / Macklin-Doherty, A. / Wu, X. / O'Brien, M.E. / Popat, S. / Yap, T. / Bhosle, J. et al. | 2016
-
137 10 years of CHART (continuous hyperfractionated accelerated radiotherapy) for non-small cell lung cancer (NSCLC) at NCCCPickles, R.L. / Iqbal, S. / Mulvenna, P. / Mcmenemin, R. / Kelly, E. / Atherton, P. / Turnbull, H. / Simmons, T. / Bradshaw, A. / Mackenzie, L. et al. | 2016
-
120 Patient statisfaction with lung cancer survivorship clinicBoland, A.C. / White, J. / Callister, M.E.J. / Paramasivam, E. / Rodger, K. / Robson, J. et al. | 2016
-
77 Systemic therapy is safe and effective in octogenarians with advanced lung cancerRush, H. / Roca, J. / Dalby, M. / Smith, D. / Lal, R. / Spicer, J. / Montes, A. / Karapanagiotou, E. et al. | 2016
-
3 EGFR mutant circulating tumour DNA detection in advanced lung adenocarcinoma: optimising the application of a ctDNA diagnostic to real world clinical practicePender, A. / Rana, S. / Delgado, E. Izquierdo / Proszek, P. / Garcia-Murillas, I. / Bhosle, J. / O'Brien, M. / Palma, J.F. / Turner, N.C. / Popat, S. et al. | 2016
-
25 The impact of emergency presentations on lung cancer survival in a district general hospital – a review of new in-patient lung cancer referrals to the respiratory specialist nurse service at Conquest Hospital, East Sussex, UKFerguson, R. / Butcher, G. / Kankam, O. et al. | 2016
-
169 Social prescribing – can social groups address patients' and carers' emotional and wellbeing needs when diagnosed with mesothelioma or lung cancer?Lemon, J. / Boulger, A. / Perkins, T. / Savory, S. / Ward, M. / Darlison, L. et al. | 2016
-
192 TARGET trial – randomised controlled trial to compare the diagnostic yield of positron emission tomography computed tomography (PET-CT) TARGETed pleural biopsy versus CT-guided pleural biopsy in suspected pleural malignancyDe Fonseka, D. / Maskell, N. et al. | 2016
-
64 Management of EGFR tyrosine kinase inhibitor associated skin toxicity: a single centre experienceThomas, L. / Hadaki, M. / Sevitt, T. / Shah, R. / Burcombe, R. / Hall, J. / Taylor, H. / Beesley, S. / Cominos, M. et al. | 2016
-
149 A review of the accuracy and efficacy of immobilisation used for patients receiving radical radiotherapy for lung cancerTodd, L. / Brown, D. / Perkins, K. et al. | 2016
-
34 Developing an integrated lung cancer system in Greater Manchester: a 3-step frameworkBayman, N. / Noor, H. et al. | 2016
-
48 The safety profile of VATS pleural biopsyVozza, A. / Stamenkovic, S. / Forty, J. et al. | 2016
-
195 A feasibility study comparing (extended) pleurectomy decortication versus no pleurectomy decortication in the multimodality management of patients with malignant pleural mesothelioma: the MARS 2 studyLim, E. et al. | 2016
-
113 Barriers to surgery in early stage lung cancer – the East Sussex experienceParker, L. / Butcher, G. / Kankam, O. et al. | 2016
-
178 Postchemotherapy resection of malignant mediastinal germ cell tumours – does persistent malignancy matter?Di Martino, M. / Dhanji, A. / Shamash, J. / Wood, A. / Lau, K. et al. | 2016
-
86 When RON MET TAM: potential interventions for mesothelioma therapyBaird, A. / Easty, D. / Mohamed, B.M. / Jarzabek, M.A. / Sheils, L. / Soltermann, A. / Raeppel, S. / Mcdonagh, L. / Clarke, G. / Crosbie-Staunton, K. et al. | 2016
-
97 Using Your Voice 2014 – how to use your nursing voice at the MDTMagee, L. / Roberts, J. / Beattie, V. / De Normanville, C. / Borthwick, D. et al. | 2016
-
36 The use of audit to improve resection rates in non-small cell lung cancer in EssexVan Zeller, C. / Lawson, M. / Yung, B. / Cooper, S. / Powrie, D. et al. | 2016
-
51 An audit of CTPA imaging within University Hospitals of LeicesterOwen, D.J. / Lames, J. / Thraves, O. / Magondo, P. / Gupta, S. / Bajaj, A. et al. | 2016
-
44 Audit on hyponatraemia in lung cancer – prevalence and clinical significanceRoux, R. / Desouza, K. / Dickson, J. / Polychronis, A. et al. | 2016
-
20 Transformation of EML4/ALK positive adenocarcinoma of the lung to small cell lung cancer following ALK targeted therapyLees, C.E. / Woodcock, V. / Nicholson, A. / Talbot, D. et al. | 2016
-
12 mRNA helicases as therapeutic targets in lung cancerRaza, F. / Das, M. / Le Quesne, J. et al. | 2016
-
127 Outcome of CyberKnife radiosurgery for early stage lung cancerMahmood, B. / Conibear, J. / Wells, P. et al. | 2016
-
154 Chemotherapy treatment rates and survival in poor performance status small cell lung cancer at a district general hospitalReinius, M. / Rimmer, Y. / Pulimood, T. / Patterson, D.M. et al. | 2016